Cancer Therapeutics [electronic resource] : Experimental and Clinical Agents / edited by Beverly A. Teicher.

9781592597178

Totowa, NJ : Humana Press : Imprint: Humana Press, 1997.

XII, 451 p. digital.

Access is available to the Yale community.

Access restricted by licensing agreement.

This comprehensive review of existing and potential anticancer drugs and therapies by leading researchers from academia, government laboratories, and pharmaceutical companies offers essential insight into what has been accomplished and where the experimental therapy of cancer is going. The authoritative contributors illuminate the current status of the major molecules of cancer treatment, ranging from the nitrogen mustards through platinum complexes to interferons, cytokines, growth factors and their inhibitors, and on to immunotoxins, antisense oligonucleotides, and gene therapy. A companion volume by the same editor (Anticancer Drug Development Guide: Preclinical and Clinical Screening and Approval) details the processes by which new anticancer drugs are approved. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field.

Springer ebooks.

Printed edition:

Books / Online

English

May 15, 2013

SpringerLink (Online service)